Physician profile
Daniel John Chu
NPI 1811424740
$34,507.00
in general payments reported to CMS, 2019-2025
12 companies · $10K in 2025
The $10K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $108 · 2022: $217 · 2023: $499 · 2024: $23K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $33K · Food and Beverage: $1,182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $33,000.00 |
| Food and Beverage | $1,181.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30,340.03 | 2023-2025 | General - Atherectomy, Watchman |
| Medtronic, INC. | $3,341.51 | 2024-2025 | Cardioblate, Symplicity G3, Affera Mapping System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $219.54 | 2021-2023 | Lifevest |
| Smith+Nephew, INC. | $142.70 | 2023 | Grafix Pl |
| Abiomed | $140.18 | 2024-2025 | Impella |
| Edwards Lifesciences Corporation | $100.27 | 2025 | Evoque |
| Astrazeneca Pharmaceuticals Lp | $71.61 | 2022-2023 | Andexxa |
| Irhythm Technologies, INC. | $64.12 | 2022-2024 | Zio Monitor, Zio Xt Patch |
| Teleflex LLC | $36.27 | 2022-2024 | Supercross |
| Kestra Medical Technology Services, INC. | $28.76 | 2022 | |
| Philips North America LLC | $17.72 | 2024 | (5044) Mcot |
| Reflow Medical INC | $4.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.